Findings from several studies have indicated that SIRT7 combines with chromatin and catalyzes the selective deacetylation of H3K18, an epigenetic biomarker of malignant tumors and an indicator of poor prognosis in patients [37, 38]. This evidence concerns the gene SIRT7 and cancer.